BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 21349667)

  • 1. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
    Isebaert S; De Keyzer F; Haustermans K; Lerut E; Roskams T; Roebben I; Van Poppel H; Joniau S; Oyen R
    Eur J Radiol; 2012 Mar; 81(3):e217-22. PubMed ID: 21349667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [
    Zhao J; Kader A; Mangarova DB; Brangsch J; Brenner W; Hamm B; Makowski MR
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis.
    Dikaios N; Atkinson D; Tudisca C; Purpura P; Forster M; Ahmed H; Beale T; Emberton M; Punwani S
    Comput Med Imaging Graph; 2017 Mar; 56():1-10. PubMed ID: 28192761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MR imaging in identifying active anal fistula after surgery.
    Lu W; Li X; Liang W; Chen K; Cao X; Zhou X; Wang Y; Huang B
    BMC Med Imaging; 2024 Apr; 24(1):76. PubMed ID: 38561667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of whole-mount histopathology in prostate cancer: current applications and future prospects.
    Duan L; Liu Z; Wan F; Dai B
    BMC Cancer; 2024 Apr; 24(1):448. PubMed ID: 38605339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T.
    Vos EK; Litjens GJ; Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Huisman HJ; Scheenen TW
    Eur Urol; 2013 Sep; 64(3):448-55. PubMed ID: 23751135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer.
    Chen YJ; Chu WC; Pu YS; Chueh SC; Shun CT; Tseng WY
    J Magn Reson Imaging; 2012 Oct; 36(4):912-9. PubMed ID: 22711415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full resolution reconstruction of whole-mount sections from digitized individual tissue fragments.
    Schouten D; van der Laak J; van Ginneken B; Litjens G
    Sci Rep; 2024 Jan; 14(1):1497. PubMed ID: 38233535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Contrast-Enhanced Study in the mpMRI of the Prostate-Unnecessary or Underutilised? A Narrative Review.
    Guljaš S; Dupan Krivdić Z; Drežnjak Madunić M; Šambić Penc M; Pavlović O; Krajina V; Pavoković D; Šmit Takač P; Štefančić M; Salha T
    Diagnostics (Basel); 2023 Nov; 13(22):. PubMed ID: 37998624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal length and temporal resolution of dynamic contrast-enhanced MR imaging for the differentiation between prostate cancer and normal peripheral zone tissue.
    Hellstern M; Martinez C; Wallenhorst C; Beyersdorff D; Lüdemann L; Grimm MO; Teichgräber U; Franiel T
    PLoS One; 2023; 18(6):e0287651. PubMed ID: 37352312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-quantitative and quantitative dynamic contrast-enhanced (DCE) MRI parameters as prostate cancer imaging biomarkers for biologically targeted radiation therapy.
    Reynolds HM; Tadimalla S; Wang YF; Montazerolghaem M; Sun Y; Williams S; Mitchell C; Finnegan ME; Murphy DG; Haworth A
    Cancer Imaging; 2022 Dec; 22(1):71. PubMed ID: 36536464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting DCE-MRI: Classification of Prostate Tissue Using Descriptive Signal Enhancement Features Derived From DCE-MRI Acquisition With High Spatiotemporal Resolution.
    Breit HC; Block TK; Winkel DJ; Gehweiler JE; Glessgen CG; Seifert H; Wetterauer C; Boll DT; Heye TJ
    Invest Radiol; 2021 Sep; 56(9):553-562. PubMed ID: 33660631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence.
    Baur ADJ; Hansen CM; Rogasch J; Posch H; Elezkurtaj S; Maxeiner A; Erb-Eigner K; Makowski MR
    Sci Rep; 2020 Feb; 10(1):3121. PubMed ID: 32080281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models.
    Fiordelisi MF; Auletta L; Meomartino L; Basso L; Fatone G; Salvatore M; Mancini M; Greco A
    Contrast Media Mol Imaging; 2019; 2019():8946729. PubMed ID: 31598114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
    Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
    Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histogram analysis of prostate cancer on dynamic contrast-enhanced magnetic resonance imaging: A preliminary study emphasizing on zonal difference.
    Lai CC; Huang PH; Wang FN; Shen SH; Wang HK; Liu HT; Chung HJ; Lin TP; Chang YH; Pan CC; Peng SL
    PLoS One; 2019; 14(2):e0212092. PubMed ID: 30753222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatic Prostate Cancer Segmentation Using Kinetic Analysis in Dynamic Contrast-Enhanced MRI.
    Navaei Lavasani S; Mostaar A; Ashtiyani M
    J Biomed Phys Eng; 2018 Mar; 8(1):107-116. PubMed ID: 29732345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
    He D; Chatterjee A; Fan X; Wang S; Eggener S; Yousuf A; Antic T; Oto A; Karczmar GS
    Invest Radiol; 2018 Oct; 53(10):609-615. PubMed ID: 29702525
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.